FindTrial
Sign In

Biased cion up-down determination of the 95% effective dose of propofol combined with sufentanil and midazolam for deep basic aneshtesia in pediatric patients

Biased cion up-down determination of the 95% effective dose of propofol combined with sufentanil and midazolam for deep basic anesthesia in pediatric patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030242
Enrollment
Unknown
Registered
2020-02-25
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric basic anesthesia

Interventions

Group B:midazolam
Group C:sufentani
Group A:propofol

Sponsors

First affiliated Hospital of Tsinghua University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Pediatric patients in need of arterial line placement before operation or pediatric patients in need of central vena catheterization in the ward; 2. ASA score I, II; 3. Aged 1 month to 6 years; 4. Signed informed consent by parents or legal guardians.

Exclusion criteria

Exclusion criteria: 1. Pediatric patient with complex congenital heart disease; 2. Patients with allergic history to the drugs used.

Design outcomes

Primary

MeasureTime frame
body movement;—

Secondary

MeasureTime frame
vital signs;respiratory depression;doctor's satisfaction;—

Countries

China

Contacts

Public ContactLi Huixian

Department of Anesthesiology, First affiliated hospital of Tsinghua University

18611850822@163.com+86 18611850822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026